Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRS3 | P32247 | 6/20 | 0.41 |
| ▸ | AGTR1 | P30556 | 6/20 | 0.40 |
| ▸ | AGTR2 | P50052 | 5/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | MME | P08473 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 2/20 | 0.36 |
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6004555 | 0.90 | AGTR1 (0.50) | BRS3AGTR1AGTR2MME | |
| SCHEMBL6005760 | 0.83 | BRS3 (0.51) | BRS3AGTR1AGTR2MME | |
| SCHEMBL9741307 | 0.82 | AGTR1 (0.51) | AGTR1AGTR2MME | |
| SCHEMBL9737737 | 0.80 | BRS3 (0.42) | BRS3AGTR1AGTR2FOLH1MME | |
| SCHEMBL9531976 | 0.78 | AGTR1 (0.40) | AGTR1AGTR2FOLH1 | |
| SCHEMBL6005810 | 0.78 | AGTR1 (0.45) | BRS3AGTR1AGTR2MME | |
| SCHEMBL9528902 | 0.78 | AGTR1 (0.49) | BRS3AGTR1AGTR2FOLH1MME | |
| SCHEMBL9529366 | 0.77 | AGTR1 (0.38) | BRS3AGTR1AGTR2MME | |
| SCHEMBL6007714 | 0.77 | AGTR1 (0.47) | BRS3AGTR1AGTR2 | |
| SCHEMBL6007277 | 0.77 | AGTR1 (0.54) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0527851-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-02-24 | — | — | EP | disclosed |
| WO-1991017148-A1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-11-14 | — | — | WO | disclosed |